Patient Perceptions of Care Coordination during Neoadjuvant Therapy for Gastrointestinal Cancers: A Mixed Methods Analysis.
Cancer care coordination
Gastrointestinal cancer
Mixed-methods analysis
Neoadjuvant therapy
Journal
Journal of gastrointestinal cancer
ISSN: 1941-6636
Titre abrégé: J Gastrointest Cancer
Pays: United States
ID NLM: 101479627
Informations de publication
Date de publication:
14 Feb 2024
14 Feb 2024
Historique:
accepted:
07
02
2024
medline:
14
2
2024
pubmed:
14
2
2024
entrez:
14
2
2024
Statut:
aheadofprint
Résumé
Effective cancer care coordination (CCC) is an integral component of health care delivery and critical to achieving optimal oncologic outcomes. Neoadjuvant therapy (NT), the delivery of multimodality therapy prior to surgery, is inherently complex and multidisciplinary, but CCC during NT is poorly understood. The objective of this study was to characterize patient perceptions of CCC during NT using a mixed methods approach. This study is a cross-sectional analysis of patients with gastrointestinal cancers receiving NT who participated in a prospective longitudinal cohort study evaluating their real-time experience using a customized smartphone application. Patients completed the Cancer Care Coordination Questionnaire for Patients (CCCQ-P), a 20-item validated measure of care coordination quality, six weeks after initiating NT. Items were scored on a 5-point Likert scale, and subsections on communication (13 questions) and navigation (7 questions) were calculated with higher scores signifying better CCC. Univariate linear regression was used to calculate the impact of fragmented care and other factors on perceived CCC. Semi-structured interviews were conducted among a convenience sample of patients (n = 5); transcribed interviews were then coded using an inductive approach. Among 82 participants, mean age was 61 years old, 68% were male, and mean number of comorbidities was 1.68. Overall (mean 76.6 out of 100), communication subsection (48.6 out of 65), and navigation subsection (28.0 out of 35) CCCQ-P scores suggested overall positive perceptions of care coordination. Qualitative analysis of patient interviews highlighted the need for coordination among physicians before communicating the plan to patients as well as the importance of providers communicating plans in verbal and written form. Successful completion of NT requires significant care coordination between patients and healthcare professionals. Yet, in this cross-sectional analysis of patients on a prospective cohort study, patient perceptions of CCC during NT were overall positive. Future research should focus on optimizing other aspects of care delivery in order to improve outcomes of NT.
Identifiants
pubmed: 38351391
doi: 10.1007/s12029-024-01030-w
pii: 10.1007/s12029-024-01030-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Aquina CT, Ejaz A, Tsung A, Pawlik TM, Cloyd JM. National trends in the use of neoadjuvant therapy before cancer surgery in the US from 2004 to 2016. JAMA Netw Open. 2021;4:e211031. https://doi.org/10.1001/jamanetworkopen.2021.1031 .
doi: 10.1001/jamanetworkopen.2021.1031
pubmed: 33688961
pmcid: 7948056
Cloyd JM, Heh V, Pawlik TM, Ejaz A, Dillhoff M, Tsung A, Williams T, Abushahin L, Bridges JFP, Santry H. Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials. J Clin Med. 2020;9(4):1129. https://doi.org/10.3390/jcm9041129 .
doi: 10.3390/jcm9041129
pubmed: 32326559
pmcid: 7231310
Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20. https://doi.org/10.1056/nejmoa055531 .
doi: 10.1056/nejmoa055531
pubmed: 16822992
van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–84. https://doi.org/10.1056/NEJMoa1112088 .
doi: 10.1056/NEJMoa1112088
pubmed: 22646630
Conroy T, Bosset JF, Etienne PL, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:702–15. https://doi.org/10.1016/s1470-2045(21)00079-6 .
doi: 10.1016/s1470-2045(21)00079-6
pubmed: 33862000
Fiore M, Palassini E, Fumagalli E, et al. Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST). Eur J Surg Oncol. 2009;35:739–45. https://doi.org/10.1016/j.ejso.2008.11.005 .
doi: 10.1016/j.ejso.2008.11.005
pubmed: 19110398
Committee on Improving the Quality of Cancer Care: Addressing the Challenges of an Aging P, Board on Health Care S, Institute of M. Levit L, Balogh E, Nass S, Ganz PA, editors. Delivering high-quality cancer care: Charting a new course for a system in crisis. Washington (DC): National Academies Press (US). Copyright 2013 by the National Academy of Sciences. All rights reserved. 2013.
McDonald KM, Sundaram V, Bravata DM, et al. AHRQ technical reviews. In: Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies (Vol. 7: Care Coordination). Rockville (MD): Agency for Healthcare Research and Quality (US); 2007.
Collett GK, Durcinoska I, Rankin NM, et al. Patients’ experience of lung cancer care coordination: a quantitative exploration. Support Care Cancer. 2019;27:485–93. https://doi.org/10.1007/s00520-018-4338-3 .
doi: 10.1007/s00520-018-4338-3
pubmed: 29980906
Durcinoska I, Young JM, Solomon MJ. Patterns and predictors of colorectal cancer care coordination: A population-based survey of Australian patients. Cancer. 2017;123:319–26. https://doi.org/10.1002/cncr.30326 .
doi: 10.1002/cncr.30326
pubmed: 27603147
Bath NM, Sarna A, Palettas M, Monsour C, Stevens L, Santry H, Ejaz A, Kim A, Pawlik T, Cloyd JM. Characterizing treatment burden during neoadjuvant therapy for patients with gastrointestinal cancer: A mixed methods analysis. J Surg Oncol. 2023;128(2):393–401. https://doi.org/10.1002/jso.27288 .
doi: 10.1002/jso.27288
pubmed: 37079430
Ruff SM, Stevens L, Bressler L, et al. Evaluating the caregiver experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma. J Surg Oncol. 2023. https://doi.org/10.1002/jso.27558 .
doi: 10.1002/jso.27558
pubmed: 38063046
King M, Jones L, Richardson A, et al. The relationship between patients’ experiences of continuity of cancer care and health outcomes: a mixed methods study. Br J Cancer. 2008;98:529–36. https://doi.org/10.1038/sj.bjc.6604164 .
doi: 10.1038/sj.bjc.6604164
pubmed: 18231111
pmcid: 2243159
Cloyd JM, Hyman S, Huwig T, et al. Patient experience and quality of life during neoadjuvant therapy for pancreatic cancer: a systematic review and study protocol. Support Care Cancer. 2021;29:3009–16. https://doi.org/10.1007/s00520-020-05813-2 .
doi: 10.1007/s00520-020-05813-2
pubmed: 33030596
Shannon AH, Sarna A, Bressler L, et al. Quality of life and real-time patient experience during neoadjuvant therapy: a prospective cohort study. Ann Surg. 2023. https://doi.org/10.1097/sla.0000000000006090 .
doi: 10.1097/sla.0000000000006090
pubmed: 37641957
Young JM, Walsh J, Butow PN, Solomon MJ, Shaw J. Measuring cancer care coordination: development and validation of a questionnaire for patients. BMC Cancer. 2011;11:298. https://doi.org/10.1186/1471-2407-11-298 .
doi: 10.1186/1471-2407-11-298
pubmed: 21756360
pmcid: 3151230
Young JM, Butow PN, Walsh J, et al. Multicenter randomized trial of centralized nurse-led telephone-based care coordination to improve outcomes after surgical resection for colorectal cancer: The CONNECT intervention. J Clin Oncol. 2013;31:3585–91. https://doi.org/10.1200/jco.2012.48.1036 .
doi: 10.1200/jco.2012.48.1036
pubmed: 24002519
Bradley EH, Curry LA, Devers KJ. Qualitative data analysis for health services research: developing taxonomy, themes, and theory. Health Serv Res. 2007;42:1758–72. https://doi.org/10.1111/j.1475-6773.2006.00684.x .
doi: 10.1111/j.1475-6773.2006.00684.x
pubmed: 17286625
pmcid: 1955280
Institute of Medicine Committee on Quality of Health Care in America. Crossing the quality chasm: A new health system for the 21st century. Washington (DC): National Academies Press (US). Copyright 2001 by the National Academy of Sciences. All rights reserved. 2001.
The NCI strategic plan for leading the nation to eliminate the suffering and death due to cancer. In, editor^editors. [Washington, D.C.?]: National Cancer Institute, U.S. Department of Health and Human Services. 2006.
Okado I, Cassel K, Pagano I, Holcombe RF. Development and psychometric evaluation of a questionnaire to measure cancer patients’ perception of care coordination. BMC Health Serv Res. 2020;20:52. https://doi.org/10.1186/s12913-020-4905-4 .
doi: 10.1186/s12913-020-4905-4
pubmed: 31964391
pmcid: 6975072
Gorin SS, Haggstrom D, Han PKJ, Fairfield KM, Krebs P, Clauser SB. Cancer care coordination: a systematic review and meta-analysis of over 30 years of empirical studies. Ann Behav Med. 2017;51:532–46. https://doi.org/10.1007/s12160-017-9876-2 .
doi: 10.1007/s12160-017-9876-2
pubmed: 28685390
Beesley VL, Janda M, Burmeister EA, et al. Association between pancreatic cancer patients’ perception of their care coordination and patient-reported and survival outcomes. Palliat Support Care. 2018;16:534–43. https://doi.org/10.1017/s1478951517000608 .
doi: 10.1017/s1478951517000608
pubmed: 28669376
Stevens L, Brown ZJ, Zeh R, et al. Characterizing the patient experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma: a qualitative study. World J Gastrointest Oncol. 2022;14:1175–86. https://doi.org/10.4251/wjgo.v14.i6.1175 .
doi: 10.4251/wjgo.v14.i6.1175
pubmed: 35949220
pmcid: 9244990
Forbes Shepherd R, Bradford A, Lieschke M, Shackleton K, Hyatt A. Patient communication and experiences in cancer clinical drug trials: a mixed-method study at a specialist clinical trials unit. Trials. 2023;24:400. https://doi.org/10.1186/s13063-023-07284-2 .
doi: 10.1186/s13063-023-07284-2
pubmed: 37312206
pmcid: 10262501
Kronenfeld JP, Collier AL, Turgeon MK, et al. Attrition during neoadjuvant chemotherapy for gastric adenocarcinoma is associated with decreased survival: a United States safety-net collaborative analysis. J Surg Oncol. 2021;124:1317–28. https://doi.org/10.1002/jso.26638 .
doi: 10.1002/jso.26638
pubmed: 34379324
pmcid: 8595640
Brown ZJ, Heh V, Labiner HE, et al. Surgical resection rates after neoadjuvant therapy for localized pancreatic ductal adenocarcinoma: meta-analysis. Br J Surg. 2022;110:34–42. https://doi.org/10.1093/bjs/znac354 .
doi: 10.1093/bjs/znac354
pubmed: 36346716
Tan S, Ou Y, Huang S, Gao Q. Surgical, oncological, and functional outcomes of local and radical resection after neoadjuvant chemotherapy or chemoradiotherapy for early- and mid-stage rectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2023;38:132. https://doi.org/10.1007/s00384-023-04433-6 .
doi: 10.1007/s00384-023-04433-6
pubmed: 37193915
Fong ZV, Verdugo FL, Fernandez-Del Castillo C, et al. Tolerability, attrition rates, and survival outcomes of neoadjuvant FOLFIRINOX for nonmetastatic pancreatic adenocarcinoma: intent-to-treat analysis. J Am Coll Surg. 2023;236:1126–36. https://doi.org/10.1097/xcs.0000000000000499 .
doi: 10.1097/xcs.0000000000000499
pubmed: 36729817